Shire (NAS: SHPG.Y) reported earnings on Feb. 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Shire beat slightly on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share improved significantly.
Gross margins contracted, operating margins improved, and net margins improved.
Shire reported revenue of $1.14 billion. The 19 analysts polled by S&P Capital IQ predicted revenue of $1.13 billion. GAAP sales were 23% higher than the prior-year quarter's $931.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $1.51. The 16 earnings estimates compiled by S&P Capital IQ anticipated $1.37 per share on the same basis. GAAP EPS of $0.44 for Q4 were 52% higher than the prior-year quarter's $0.29 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 86.6%, 30 basis points worse than the prior-year quarter. Operating margin was 27.9%, 600 basis points better than the prior-year quarter. Net margin was 22.4%, 460 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.15 billion. On the bottom line, the average EPS estimate is $1.46.
Next year's average estimate for revenue is $4.77 billion. The average EPS estimate is $6.12.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Shire is outperform, with an average price target of $107.79.
The drug and healthcare investing landscape is littered with also-rans and a few major winners. Is Shire the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
Add Shire to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.